Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cheetham

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Biological Psychiatry|September 15, 1990
Symmetrical hemispheric distribution of 3H-paroxetine binding sites in postmortem human brain from controls and suicidesK M Lawrence, F De Paermentier, S C Cheetham, et al.
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Corticotropin-releasing factor immunoreactivity in post-mortem brain from depressed suicidesB G Charlton, S C Cheetham, R W Horton, et al.
European Journal of Biochemistry|October 17, 1983
A potent new dipeptide inhibitor of cell sickling and haemoglobin S gelationI M Franklin, R I Cotter, R C Cheetham, et al.
British Journal of Pharmacology|December 1, 1989
Brain 5-HT uptake sites, labelled with [3H]-paroxetine, in post-mortem samples from depressed suicide victimsK M Lawrence, F De Paermentier, S C Cheetham, et al.
Brain Research|August 27, 1990
Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicidesK M Lawrence, F De Paermentier, S C Cheetham, et al.
Brain Research|March 28, 1997
Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controlsC Bowden, A E Theodorou, S C Cheetham, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 26, 2014
Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria dietSteven P Vickers, Sharon C Cheetham, Katie R Headland, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2016
Electromyographic evidence in support of a knock-in mouse model of DYT1 DystoniaMark P DeAndrade, Amy Trongnetrpunya, Fumiaki Yokoi, et al.
Journal of Molecular Biology|August 5, 1986
Molecular dynamics simulations of native and substrate-bound lysozyme. A study of the average structures and atomic fluctuationsC B Post, B R Brooks, M Karplus, et al.
Therapeutic Drug Monitoring|January 1, 1986
Matched case-control study of adjusted versus nonadjusted gentamicin dosing in perforated and gangrenous appendicitisM A Gill, T C Cheetham, F C Chenella, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Biological Psychiatry|September 15, 1990
Symmetrical hemispheric distribution of 3H-paroxetine binding sites in postmortem human brain from controls and suicidesK M Lawrence, F De Paermentier, S C Cheetham, et al.
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Corticotropin-releasing factor immunoreactivity in post-mortem brain from depressed suicidesB G Charlton, S C Cheetham, R W Horton, et al.
European Journal of Biochemistry|October 17, 1983
A potent new dipeptide inhibitor of cell sickling and haemoglobin S gelationI M Franklin, R I Cotter, R C Cheetham, et al.
British Journal of Pharmacology|December 1, 1989
Brain 5-HT uptake sites, labelled with [3H]-paroxetine, in post-mortem samples from depressed suicide victimsK M Lawrence, F De Paermentier, S C Cheetham, et al.
Brain Research|August 27, 1990
Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicidesK M Lawrence, F De Paermentier, S C Cheetham, et al.
Brain Research|March 28, 1997
Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controlsC Bowden, A E Theodorou, S C Cheetham, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 26, 2014
Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria dietSteven P Vickers, Sharon C Cheetham, Katie R Headland, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2016
Electromyographic evidence in support of a knock-in mouse model of DYT1 DystoniaMark P DeAndrade, Amy Trongnetrpunya, Fumiaki Yokoi, et al.
Journal of Molecular Biology|August 5, 1986
Molecular dynamics simulations of native and substrate-bound lysozyme. A study of the average structures and atomic fluctuationsC B Post, B R Brooks, M Karplus, et al.
Therapeutic Drug Monitoring|January 1, 1986
Matched case-control study of adjusted versus nonadjusted gentamicin dosing in perforated and gangrenous appendicitisM A Gill, T C Cheetham, F C Chenella, et al.
Pageof 10